Working… Menu

Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03014297
Recruitment Status : Terminated (Part I completed. Part 2 will not be done due to sponsor decision.)
First Posted : January 9, 2017
Last Update Posted : August 8, 2019
Information provided by (Responsible Party):
Lowell Anthony, MD, University of Kentucky

No Study Results Posted on for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : June 5, 2018
Actual Study Completion Date : November 16, 2018